A carregar...
Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker
BCR-ABL is a key mediator in the pathogenesis of all cases of chronic myelogenous leukemia (CML) and a subset of precursor B-acute lymphoblastic leukemia (Ph+ALL). Previous animal and cell-based studies have shown that the expression of members of the Forkhead family of tumor suppressors, including...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3087959/ https://ncbi.nlm.nih.gov/pubmed/21282974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.11.6.14675 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|